抑制SIRT2通过FOXO1乙酰化介导的自噬激活减轻脓毒症诱导的急性肾损伤
本研究探索SIRT2作为脓毒症相关急性肾损伤(SAKI)治疗靶点的潜力。在盲肠结扎穿孔脓毒症小鼠中,SIRT2拮抗剂AGK2预处理改善生存,并降低KIM-1、NGAL、血清肌酐、血尿素氮及促炎细胞因子水平,同时增加肾小管上皮细胞自噬体和自噬溶酶体形成、上调肾皮质LC3 II表达。在LPS处理的HK-2细胞中,SIRT2基因沉默促进自噬而过表达抑制自噬。机制上,抑制SIRT2增加FOXO1乙酰化,诱导其核转质转位,从而促进肾脏自噬、减轻SAKI。作者认为SIRT2是SAKI治疗的潜在靶点。
要点
- 在盲肠结扎穿孔脓毒症小鼠中,SIRT2拮抗剂AGK2预处理改善生存率。
- AGK2预处理降低脓毒症小鼠KIM-1、NGAL、血清肌酐、血尿素氮及促炎细胞因子水平,减轻肾损伤。
- AGK2预处理增加脓毒症小鼠肾小管上皮细胞自噬体与自噬溶酶体形成,上调肾皮质LC3 II表达。
- LPS处理的HK-2细胞中,SIRT2基因沉默促进自噬,SIRT2过表达抑制自噬。
- 机制上,抑制SIRT2增加FOXO1乙酰化,诱导其核转质转位,促进肾脏自噬并减轻SAKI。
适用人群与场景
- 盲肠结扎穿孔脓毒症小鼠模型
- LPS处理的HK-2细胞
处置流程与药物剂量
- SIRT2拮抗剂AGK2用于脓毒症小鼠预处理,改善生存并减轻肾损伤;原文未写明剂量、给药途径与疗程。
研究设计与关键结果
- 动物实验:AGK2抑制SIRT2改善脓毒症小鼠生存,降低KIM-1、NGAL、血清肌酐、血尿素氮及促炎细胞因子水平,增加肾小管上皮细胞自噬体与自噬溶酶体形成,上调肾皮质LC3 II表达。
- 细胞实验:LPS处理的HK-2细胞中SIRT2基因沉默促进自噬,SIRT2过表达抑制自噬。
- 机制:抑制SIRT2增加FOXO1乙酰化,诱导其核转质转位,促进肾脏自噬并减轻SAKI。
- 作者结论:SIRT2是SAKI治疗的潜在靶点。
证据类型、等级与局限
- 证据类型:动物实验与细胞实验(基础研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为SIRT2是SAKI治疗的潜在靶点,AGK2在脓毒症小鼠中改善生存并减轻肾损伤;上述结果来自动物与细胞实验,尚未提供临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis-associated acute kidney injury (SAKI), a common complication in intensive care units (ICUs), is linked to high morbidity and mortality. Sirtuin 2 (SIRT2), an NAD + -dependent deacetylase, has been shown to have distinct effects on autophagy regulation compared to other sirtuins, but its role in SAKI remains unclear. This study explored the potential of SIRT2 as a therapeutic target for SAKI. We found that inhibition of SIRT2 with the antagonist AGK2 improved the survival of septic mice. SIRT2 inhibition reduced kidney injury, as indicated by lower levels of KIM-1, NGAL, serum creatinine, blood urea nitrogen, and proinflammatory cytokines following cecal ligation and puncture. Pretreatment with AGK2 in septic mice increased autophagosome and autolysosome formation in renal tubular epithelial cells and upregulated LC3 II expression in the renal cortex. Consistent with in vivo findings, SIRT2 gene silencing promoted autophagy in LPS-treated HK-2 cells, whereas SIRT2 overexpression inhibited it. Mechanistically, SIRT2 inhibition increased FOXO1 acetylation, inducing its nuclear-to-cytoplasmic translocation, which promoted kidney autophagy and alleviated SAKI. Our study suggests SIRT2 as a potential target for SAKI therapy.
参考来源
- Yu B, Weng L, Li J, et al. INHIBITING SIRT2 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY VIA FOXO1 ACETYLATION-MEDIATED AUTOPHAGY ACTIVATION. Shock. 2024. PMID: 39527461. doi:10.1097/SHK.0000000000002505
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。